Skip to main content

MARSHALL WACE, LLP

Position in STLN — Starling Oncology, Inc.

CIK 1318757 LONDON, X0

Position in STLN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$6,638,163
+$5,587,410 QoQ
Shares Held
1,222,498
+257.2% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#12
of 120 holders
Holding Since
Sep 2021
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in STLN Over Time

Shares Held

Position Value (USD)

Derivatives in STLN

reported options exposure · as of Sep 30, 2022
CallValue
$0
CallShares
62,506
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Care Facilities

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $288,358,751 across 31 Medical Care Facilities names. STLN ranks #11 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STLN

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,638,163 1,222,498
2026-03-31 $1,050,753 342,265
2025-12-31 $641,868 180,300
2025-09-30 $87,821 25,164
2025-06-30 $3,027,737 1,476,946
2023-12-31 $80,135 39,282
2022-09-30 TOIIW 62,506
2022-06-30 TOIIW 62,492
2022-03-31 TOIIW 62,492
2021-12-31 TOIIW 62,492
2021-09-30 TOIIW 62,492
2021-09-30 $2,509,243 252,439